The mistakes were all the DSMB's.. Who said "E
Post# of 148278
Who said "Everything's good; keep going to hit stat sig"?
Who said "We want to look at 42 day data," which would have added two more weeks with possibly worse results, when the real comparison was at 14 days out, given LLMab was only given on days 0 and 7?
Who didn't catch a 3:1 imbalance in critical patients in LLMab vs SOC, respectively?
It's almost like they were out to wreck the study. Good thing Nader ignored that 42 day nonsense.